Want to see HK:9996 full AI Analyst Report?
Peijia Medical Ltd. (9996) Stock Statistics & Valuation Metrics
Total Valuation
Peijia Medical Ltd. has a market cap or net worth of HKD 2.55B. The enterprise value is HKD 2.46B.
- Market Cap
- HKD 2.55B
- Enterprise Value
- HKD 2.46B
Share Statistics
Peijia Medical Ltd. has 676,961,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 676,961,900
- Owned by Insiders
- ―
- Owned by Institutions
- 0.94%
Financial Efficiency
Peijia Medical Ltd.’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -8.37%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.08
- Return on Invested Capital (ROIC)
- -8.37%
- Return on Capital Employed (ROCE)
- -0.10
- Revenue Per Employee
- 690.10K
- Profits Per Employee
- -196.79K
- Employee Count
- 1,033
- Asset Turnover
- 0.27
- Inventory Turnover
- 1.55
Valuation Ratios
The current PE Ratio of Peijia Medical Ltd. is -15.11. Peijia Medical Ltd.’s PEG ratio is -0.33.
- PE Ratio
- -15.11
- PS Ratio
- 2.72
- PB Ratio
- 1.16
- Price to FCF
- -26.34
- Price to Operating Cash Flow
- 116.08
- PEG Ratio
- -0.33
Income Statement
In the last 12 months, Peijia Medical Ltd. had revenue of 712.87M and earned -203.29M in profits. Earnings per share was -0.31.
- Revenue
- 712.87M
- Gross Profit
- 486.05M
- Operating Income
- -198.67M
- Pretax Income
- -202.60M
- Net Income
- -203.29M
- EBITDA
- -128.29M
- Earnings Per Share (EPS)
- -0.31
Cash Flow
In the last 12 months, operating cash flow was 18.43M and capital expenditures -99.49M, giving a free cash flow of -81.06M billion.
- Operating Cash Flow
- 18.43M
- Free Cash Flow
- -81.06M
- Free Cash Flow per Share
- -0.12
Dividends & Yields
Peijia Medical Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.80%
- Earnings Yield
- -6.59%
Stock Price Statistics
- Beta
- 1.05
- 52-Week Price Change
- -33.98%
- 50-Day Moving Average
- 4.75
- 200-Day Moving Average
- 5.22
- Relative Strength Index (RSI)
- 30.58
- Average Volume (3m)
- 726.84K
Important Dates
Peijia Medical Ltd. upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Peijia Medical Ltd. as a current ratio of 1.21, with Debt / Equity ratio of 23.53%
- Current Ratio
- 1.21
- Quick Ratio
- 1.00
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- 1.19
- Interest Coverage Ratio
- -16.93
Taxes
In the past 12 months, Peijia Medical Ltd. has paid 5.58M in taxes.
- Income Tax
- 5.58M
- Effective Tax Rate
- -0.03
Enterprise Valuation
Peijia Medical Ltd. EV to EBITDA ratio is -84.60, with an EV/FCF ratio of -25.00.
- EV to Sales
- 2.59
- EV to EBITDA
- -84.60
- EV to Free Cash Flow
- -25.00
- EV to Operating Cash Flow
- 109.95
Balance Sheet
Peijia Medical Ltd. has HKD 761.12M in cash and marketable securities with HKD 652.57M in debt, giving a net cash position of HKD 108.55M billion.
- Cash & Marketable Securities
- HKD 761.12M
- Total Debt
- HKD 652.57M
- Net Cash
- HKD 108.55M
- Net Cash Per Share
- HKD 0.16
- Tangible Book Value Per Share
- HKD 1.67
Margins
Gross margin is 67.41%, with operating margin of -15.49%, and net profit margin of -17.98%.
- Gross Margin
- 67.41%
- Operating Margin
- -15.49%
- Pretax Margin
- -16.95%
- Net Profit Margin
- -17.98%
- EBITDA Margin
- -3.06%
- EBIT Margin
- -12.28%
Analyst Forecast
The average price target for Peijia Medical Ltd. is HKD 10.34, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- HKD 10.34
- Price Target Upside
- 174.40% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 21.23%
- EPS Growth Forecast
- 36.89%
Scores
- Smart Score
- ―
- AI Score
- 47.5